{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:24Z","timestamp":1792785024486,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Wei\u2019ai Public Welfare Foundation","award":["JVI2024-0101231021"],"award-info":[{"award-number":["JVI2024-0101231021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19890-y","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:27:10Z","timestamp":1760606830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Single-cell multi-omics uncovers CPS1 as a breast cancer immune evasion therapeutic target"],"prefix":"10.1038","volume":"15","author":[{"given":"Jian","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dele","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"19890_CR1","first-page":"145","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L. et al. Colorectal cancer statistics. CA Cancer J. Clin. 70, 145\u2013164 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"19890_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41419-017-0063-y","volume":"9","author":"TV Denisenko","year":"2018","unstructured":"Denisenko, T. V., Budkevich, I. N. & Zhivotovsky, B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 9, 117 (2018).","journal-title":"Cell Death Dis."},{"key":"19890_CR3","first-page":"1797528","volume":"5","author":"J Carrasquilla","year":"2020","unstructured":"Carrasquilla, J. Machine learning for quantum matter. Adv. Phys.X. 5, 1797528 (2020).","journal-title":"Adv. Phys.X."},{"key":"19890_CR4","doi-asserted-by":"publisher","first-page":"011002","DOI":"10.1088\/2632-2153\/abb93a","volume":"2","author":"E Cuoco","year":"2021","unstructured":"Cuoco, E. et al. Enhancing gravitational-wave science with machine learning. Mach. Learn.Sci. Technol. 2, 011002 (2021).","journal-title":"Mach. Learn.Sci. Technol."},{"key":"19890_CR5","doi-asserted-by":"publisher","first-page":"106587","DOI":"10.1016\/j.ymssp.2019.106587","volume":"138","author":"YG Lei","year":"2020","unstructured":"Lei, Y. G. et al. Applications of machine learning to machine fault diagnosis: A review and roadmap. Mech. Syst Signal Process. 138, 106587 (2020).","journal-title":"Mech. Syst Signal Process."},{"key":"19890_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1139\/gen-2020-0131","volume":"64","author":"SJ MacEachern","year":"2021","unstructured":"MacEachern, S. J. & Forkert, N. D. Machine learning for precision medicine. Genome 64, 416\u2013425 (2021).","journal-title":"Genome"},{"key":"19890_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s11831-020-09405-5","volume":"28","author":"GCY Peng","year":"2021","unstructured":"Peng, G. C. Y. et al. Multiscale modeling meets machine learning: What can we learn?. Arch. Comput. Methods Eng. 28, 1017\u20131037 (2021).","journal-title":"Arch. Comput. Methods Eng."},{"key":"19890_CR8","doi-asserted-by":"publisher","first-page":"154509","DOI":"10.1016\/j.prp.2023.154509","volume":"246","author":"NM Abdelmaksoud","year":"2023","unstructured":"Abdelmaksoud, N. M. et al. Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review. Pathol. Res. Pract. 246, 154509 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"19890_CR9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1681\/ASN.2018111126","volume":"30","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Mitochondria in sepsis-induced AKI. J. Am. Soc. Nephrol. 30, 1151\u20131161 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"19890_CR10","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3390\/cells11162518","volume":"11","author":"YE Liu","year":"2022","unstructured":"Liu, Y. E. et al. An epigenetic role of mitochondria in cancer. Cells 11, 2518 (2022).","journal-title":"Cells"},{"key":"19890_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fcell.2020.00467","volume":"8","author":"KL Ma","year":"2020","unstructured":"Ma, K. L. et al. Mitophagy, mitochondrial homeostasis, and cell fate. Front. Cell Dev. Biol. 8, 467 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"19890_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","volume":"12","author":"H Mollazadeh","year":"2021","unstructured":"Mollazadeh, H. et al. Effects of statins on mitochondrial pathways. J. Cachexia. Sarcopenia Muscle 12, 237\u2013251 (2021).","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"19890_CR13","doi-asserted-by":"publisher","first-page":"151058","DOI":"10.1016\/j.ejcb.2019.151058","volume":"99","author":"H Wang","year":"2020","unstructured":"Wang, H., Liu, C., Zhao, Y. X. & Gao, G. Mitochondria regulation in ferroptosis. Eur. J. Cell Biol. 99, 151058 (2020).","journal-title":"Eur. J. Cell Biol."},{"key":"19890_CR14","doi-asserted-by":"publisher","first-page":"101378","DOI":"10.1016\/j.arr.2021.101378","volume":"70","author":"J van der Reest","year":"2021","unstructured":"van der Reest, J., Cecchino, G. N., Haigis, M. C. & Kordowitzki, P. Mitochondria: Their relevance during oocyte ageing. Ageing Res. Rev. 70, 101378 (2021).","journal-title":"Ageing Res. Rev."},{"key":"19890_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00709-019-01439-2","volume":"257","author":"SS Andrabi","year":"2020","unstructured":"Andrabi, S. S., Parvez, S. & Tabassum, H. Ischemic stroke and mitochondria: Mechanisms and targets. Protoplasma 257, 335\u2013343 (2020).","journal-title":"Protoplasma"},{"key":"19890_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich, M. T., Oertel, W. H., Surmeier, D. J. & Geibl, F. F. Mitochondrial dysfunction in Parkinson\u2019s disease\u2014A key disease hallmark with therapeutic potential. Mol. Neurodegener. 18, 83 (2023).","journal-title":"Mol. Neurodegener."},{"key":"19890_CR17","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan, D., Braganza, A. & Shiva, S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 37, 101674 (2020).","journal-title":"Redox Biol."},{"key":"19890_CR18","first-page":"3","volume":"44","author":"RZ Zhao","year":"2019","unstructured":"Zhao, R. Z., Jiang, S., Zhang, L. & Yu, Z. B. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 44, 3\u201315 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"19890_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jfda.2014.01.005","volume":"22","author":"PP Fu","year":"2014","unstructured":"Fu, P. P., Xia, Q. S., Hwang, H. M., Ray, P. C. & Yu, H. T. Mechanisms of nanotoxicity: Generation of reactive oxygen species. J. Food Drug Anal. 22, 64\u201375 (2014).","journal-title":"J. Food Drug Anal."},{"key":"19890_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s43018-024-00738-9","volume":"5","author":"K Wu","year":"2024","unstructured":"Wu, K., El Zowalaty, A. E., Sayin, V. I. & Papagiannakopoulos, T. The pleiotropic functions of reactive oxygen species in cancer. Nat. Cancer 5, 384\u2013399 (2024).","journal-title":"Nat. Cancer"},{"key":"19890_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang, H. et al. The role of cellular reactive oxygen species in cancer chemotherapy. J. Exp. Clin. Cancer Res. 37, 266 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"19890_CR22","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1007\/s12274-018-2092-y","volume":"11","author":"CA Ferreira","year":"2018","unstructured":"Ferreira, C. A., Ni, D. L., Rosenkrans, Z. T. & Cai, W. B. Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano Res. 11, 4955\u20134984 (2018).","journal-title":"Nano Res."},{"key":"19890_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/antiox11020225","volume":"11","author":"S Mansoor","year":"2022","unstructured":"Mansoor, S. et al. Reactive oxygen species in plants: From source to sink. Antioxidants 11, 225 (2022).","journal-title":"Antioxidants"},{"key":"19890_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/1873-3468.12956","volume":"592","author":"N Nissanka","year":"2018","unstructured":"Nissanka, N. & Moraes, C. T. Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease. FEBS Lett. 592, 728\u2013742 (2018).","journal-title":"FEBS Lett."},{"key":"19890_CR25","doi-asserted-by":"publisher","first-page":"121110","DOI":"10.1016\/j.biomaterials.2021.121110","volume":"277","author":"B Niu","year":"2021","unstructured":"Niu, B. et al. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials 277, 121110 (2021).","journal-title":"Biomaterials"},{"key":"19890_CR26","doi-asserted-by":"publisher","first-page":"108024","DOI":"10.1016\/j.pharmthera.2021.108024","volume":"233","author":"K Sumaiya","year":"2022","unstructured":"Sumaiya, K., Langford, D., Natarajaseenivasan, K. & Shanmughapriya, S. Macrophage migration inhibitory factor (MIF): A multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol. Ther. 233, 108024 (2022).","journal-title":"Pharmacol. Ther."},{"key":"19890_CR27","doi-asserted-by":"publisher","first-page":"100659","DOI":"10.1016\/j.xgen.2024.100659","volume":"4","author":"C Cao","year":"2024","unstructured":"Cao, C. et al. CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8 T cells via JAK2\/STAT3 pathway. Cell Genomics 4, 100659 (2024).","journal-title":"Cell Genomics"},{"key":"19890_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/cancers15020395","volume":"15","author":"RM Barthelmess","year":"2023","unstructured":"Barthelmess, R. M., Stijlemans, B. & Van Ginderachter, J. A. Hallmarks of cancer affected by the MIF cytokine family. Cancers 15, 395 (2023).","journal-title":"Cancers"},{"key":"19890_CR29","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","volume":"7","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. Lactate dehydrogenase a: A key player in carcinogenesis and potential target in cancer therapy. Cancer Med. 7, 6124\u20136136 (2018).","journal-title":"Cancer Med."},{"key":"19890_CR30","doi-asserted-by":"publisher","first-page":"1073971","DOI":"10.3389\/fimmu.2022.1073971","volume":"13","author":"Y-Y Tang","year":"2023","unstructured":"Tang, Y.-Y., Wang, D.-C., Wang, Y.-Q., Huang, A.-F. & Xu, W.-D. Emerging role of hypoxia-inducible factor-1\u03b1 in inflammatory autoimmune diseases: A comprehensive review. Front. Immunol. 13, 1073971 (2023).","journal-title":"Front. Immunol."},{"key":"19890_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"19890_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang, Y. & Deng, B. Hepatocellular carcinoma: Molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 42, 629\u2013652 (2023).","journal-title":"Cancer Metastasis Rev."},{"key":"19890_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct. Target. Ther. 9, 132 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"19890_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell Biol. 23, 40\u201355 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"19890_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley, R. K. & Anczukow, O. RNA splicing dysregulation and the hallmarks of cancer. Nat. Rev. Cancer 23, 135\u2013155 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"19890_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","volume":"20","author":"KM Cappell","year":"2023","unstructured":"Cappell, K. M. & Kochenderfer, J. N. Long-term outcomes following CAR T cell therapy: What we know so far. Nat. Rev. Clin. Oncol. 20, 359\u2013371 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"19890_CR37","doi-asserted-by":"publisher","first-page":"1188049","DOI":"10.3389\/fimmu.2023.1188049","volume":"14","author":"A Mitra","year":"2023","unstructured":"Mitra, A. et al. From bench to bedside: The history and progress of CAR T cell therapy. Front. Immunol. 14, 1188049 (2023).","journal-title":"Front. Immunol."},{"key":"19890_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-023-06026-3","volume":"617","author":"JS Park","year":"2023","unstructured":"Park, J. S. et al. Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance. Nature 617, 377 (2023).","journal-title":"Nature"},{"key":"19890_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41590-021-01125-7","volume":"23","author":"D Sugiura","year":"2022","unstructured":"Sugiura, D. et al. PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity. Nat. Immunol. 23, 399\u2013410 (2022).","journal-title":"Nat. Immunol."},{"key":"19890_CR40","doi-asserted-by":"publisher","first-page":"1437738","DOI":"10.3389\/fphar.2024.1437738","volume":"15","author":"X-M Sun","year":"2024","unstructured":"Sun, X.-M. et al. CPS1 augments hepatic glucagon response through CaMKII\/FOXO1 pathway. Front. Pharmacol. 15, 1437738 (2024).","journal-title":"Front. Pharmacol."},{"key":"19890_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.21037\/atm.2020.02.146","volume":"8","author":"G Wu","year":"2020","unstructured":"Wu, G. et al. CPS1 expression and its prognostic significance in lung adenocarcinoma. Ann. Transl. Med. 8, 341 (2020).","journal-title":"Ann. Transl. Med."},{"key":"19890_CR42","doi-asserted-by":"publisher","first-page":"106253","DOI":"10.1016\/j.bioorg.2022.106253","volume":"130","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Zou, Y., Lu, Y., Li, Z. & Gao, F. Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases. Bioorg. Chem. 130, 106253 (2023).","journal-title":"Bioorg. Chem."},{"key":"19890_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19890-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19890-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:07:50Z","timestamp":1760612870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19890-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19890"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19890-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal procedures were approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University (Approval No.2024#gzm02871) and performed in strict compliance with: (i) China\u2019s National Standard GB\/T 35823\u20132018 Laboratory Animal-Guideline for Ethical Review, (ii) ARRIVE 2.0 guidelines and (iii) AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. Animals were housed under specific pathogen-free (SPF) conditions with ad libitum access to food\/water. Humane endpoints were enforced by immediate euthanasia via CO\u2082 asphyxiation (30% chamber volume\/min displacement) followed by cervical dislocation when tumor volume exceeded 1000 mm\n                      3\n                      . All invasive procedures employed isoflurane anesthesia (3% in 100% O\u2082 at 1 L\/min). Prohibited agents (chloral hydrate\/ether\/chloroform) were not used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement for animal experiments"}}],"article-number":"36193"}}